Climb Bio, Inc.
USD13.36
+0.28 (+2.14%)
CEO
Aoife Brennan BCh MMSc
IPO Date
2021-08-10
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$13.20
Prev. Close
$13.08
Day Low
$12.96
Day High
$13.59
52W Low
$1.19
52W High
$13.59
Market Cap
$0.91B
Volume
1.16M
| 40,000 |
| $10.55 |
| 8 Jun 2026 | Drapkin Kimberlee C | director | A-Award | Acquired | 40,000 | $10.55 |
| 8 Jun 2026 | WILLIAMS DOUGLAS E | director | A-Award | Acquired | 40,000 | $10.55 |
| 8 Jun 2026 | Cumbo Alexander | director | A-Award | Acquired | 40,000 | $10.55 |
| 8 Jun 2026 | Thomas Stephen Basil | director | A-Award | Acquired | 40,000 | $10.55 |
| 8 Jun 2026 | Dunn Judith | director | A-Award | Acquired | 40,000 | $10.55 |
| 29 Apr 2026 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | A-Award | Acquired | 2,106,000 | $0.00 |
| 27 Feb 2026 | Thomas Stephen Basil | director | S-Sale | Disposed | 16,313 | $7.01 |
| 27 Feb 2026 | Thomas Stephen Basil | director | S-Sale | Disposed | 33,687 | $7.00 |